Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KKR & Co
KKR
|
+$705M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$675M |
| 3 |
Zoetis
ZTS
|
+$510M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$404M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$2.4B |
| 2 |
STJ
St Jude Medical
STJ
|
+$538M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$397M |
| 4 |
RTX Corp
RTX
|
+$347M |
| 5 |
Microsoft
MSFT
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.69% |
| 2 | Technology | 9.44% |
| 3 | Healthcare | 8.03% |
| 4 | Consumer Discretionary | 7.35% |
| 5 | Communication Services | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBI
3526
Trueblue
TBI
$308M
| $2.53M | ﹤0.01% |
92,490
-99,675
| -52% | -$2.54M |
|
|
PHD
3527
DELISTED
Pioneer Floating Rate Fund
PHD
| $2.53M | ﹤0.01% |
206,879
-151,726
| -42% | -$1.85M |
|
3528
Pegasystems
PEGA
$5.22B
| $2.53M | ﹤0.01% |
115,216
-114,662
| -50% | -$2.32M |
|
3529
iShares MSCI India Small-Cap ETF
SMIN
$770M
| $2.52M | ﹤0.01% |
60,099
-16,907
| -22% | -$636K |
|
|
CORE
3530
DELISTED
Core Mark Holding Co., Inc.
CORE
| $2.52M | ﹤0.01% |
80,877
-54,929
| -40% | -$1.92M |
|
3531
CONMED
CNMD
$1.49B
| $2.52M | ﹤0.01% |
56,715
-63,840
| -53% | -$2.75M |
|
3532
Invesco Dorsey Wright Utilities Momentum ETF
PUI
$54.1M
| $2.51M | ﹤0.01% |
92,081
-32,994
| -26% | -$872K |
|
|
BFK
3533
DELISTED
BlackRock Municipal Income Trust
BFK
| $2.51M | ﹤0.01% |
180,180
-110,647
| -38% | -$1.56M |
|
|
DCOM
3534
DELISTED
Dime Community Bancshares
DCOM
| $2.51M | ﹤0.01% |
123,504
-72,169
| -37% | -$1.5M |
|
3535
HEICO Corp Class A
HEI.A
$36.8B
| $2.51M | ﹤0.01% |
81,575
+2,149
| +3% | +$61.5K |
|
3536
Lexicon Pharmaceuticals
LXRX
$1.05B
| $2.5M | ﹤0.01% |
174,765
+32,276
| +23% | +$479K |
|
3537
OraSure Technologies
OSUR
$275M
| $2.48M | ﹤0.01% |
191,801
-41,602
| -18% | -$430K |
|
|
TUZ
3538
DELISTED
PIMCO 1-3 Year U.S. Treasury Index Exchange-Traded Fund
TUZ
| $2.48M | ﹤0.01% |
48,900
+8,202
| +20% | +$416K |
|
3539
Weis Markets
WMK
$1.87B
| $2.48M | ﹤0.01% |
41,520
-5,390
| -11% | -$330K |
|
3540
Theravance Biopharma
TBPH
$877M
| $2.47M | ﹤0.01% |
67,118
-55,404
| -45% | -$1.77M |
|
|
IGI
3541
Western Asset Investment Grade Defined Opportunity Trust
IGI
$94.4M
| $2.47M | ﹤0.01% |
121,200
-1,295
| -1% | -$26.6K |
|
3542
Oxford Square Capital
OXSQ
$157M
| $2.47M | ﹤0.01% |
334,494
+24,554
| +8% | +$177K |
|
|
NRT
3543
North European Oil Royalty Trust
NRT
$81.8M
| $2.47M | ﹤0.01% |
341,602
-29,404
| -8% | -$214K |
|
3544
Renasant Corp
RNST
$3.96B
| $2.46M | ﹤0.01% |
62,081
-91,147
| -59% | -$3.69M |
|
3545
Sasol
SSL
$7.24B
| $2.46M | ﹤0.01% |
83,755
-19,916
| -19% | -$582K |
|
|
PTVCB
3546
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $2.46M | ﹤0.01% |
100,560
-21,076
| -17% | -$507K |
|
3547
LendingTree
TREE
$448M
| $2.45M | ﹤0.01% |
19,570
-1,535
| -7% | -$175K |
|
|
CCC
3548
DELISTED
Calgon Carbon Corp
CCC
| $2.45M | ﹤0.01% |
167,884
-34,053
| -17% | -$523K |
|
3549
Johnson Outdoors
JOUT
$500M
| $2.45M | ﹤0.01% |
67,075
-12,909
| -16% | -$451K |
|
|
BGG
3550
DELISTED
Briggs & Stratton Corp.
BGG
| $2.45M | ﹤0.01% |
108,953
-279,357
| -72% | -$6.07M |
|
Similar funds
Morgan Stanley's Q1 2017 Portfolio in Review
As of Q1 2017, Morgan Stanley held 6,814 positions worth $325B, up 6.5% from $306B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q1 2017 filing shows 216 new, 2,666 increased, 3,277 reduced and 152 closed positions. Its largest new stake was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M. The largest sale was TotalEnergies, an estimated $2.4B.
By sector, the portfolio is most concentrated in Financials at 9.7% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
- Morgan Stanley's largest Q1 2017 buy was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M.
- Morgan Stanley added most to KKR & Co in Q1 2017, an estimated $705M increase.
- Morgan Stanley's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $2.4B.
- Morgan Stanley fully exited St Jude Medical in Q1 2017, selling an estimated $538M.
- Morgan Stanley's ten largest holdings make up 12% of its $325B portfolio in Q1 2017.
- Morgan Stanley opened 216 new positions and closed 152 in Q1 2017.
- Morgan Stanley's portfolio value rose 6.5% quarter-over-quarter to $325B.
Based on Morgan Stanley's 13F filing for Q1 2017, filed 12 May 2017.